PAA 0.00% 20.0¢ pharmaust limited

Ann: Appointment of Non-Executive Director, page-12

  1. 339 Posts.
    lightbulb Created with Sketch. 523
    "US exposure in hiring top US talent in marketing"
    Wholly agree. US networks are prime marketing targets - and a hugely valuable word-of mouth marketing strategy - especially from trusted and respected sources - like an industry-experienced exec with street cred - and a specialist in 'market and product assessments, market sizing and
    forecasting, pre-launch preparation and launch and marketing of pharmaceutical products for biopharmaceutical companies
    '.

    Yes.

    "Mayne Pharma has a full service contract development and manufacturing organisations (CDMO) specialising in novel oral and topical dose forms providing pharmaceutical development, analytical testing and commercial manufacturing to clients worldwide, with expertise in drug discovery and development, clinical trials supply and commercial manufacture from our single South Australian site."

    Local knowledge, global experience, pharmacy qualifications, marketing specialist etc. = a seriously credentialled outstanding addition to the team.


 
watchlist Created with Sketch. Add PAA (ASX) to my watchlist
(20min delay)
Last
20.0¢
Change
0.000(0.00%)
Mkt cap ! $97.24M
Open High Low Value Volume
20.0¢ 20.0¢ 19.5¢ $244.3K 1.244M

Buyers (Bids)

No. Vol. Price($)
1 100000 19.5¢
 

Sellers (Offers)

Price($) Vol. No.
20.0¢ 257206 7
View Market Depth
Last trade - 16.10pm 31/07/2024 (20 minute delay) ?
PAA (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.